To assess whether the anti-tumor effects were specific to STn+ cell targeting by the anti-STn ADCs and not due to generalized distribution of MMAE, xenografts were harvested 6 hours following administration of the last dose in each treatment group and the level of STn was assessed by flow cytometry (Figure 7B). Here, EEF1A2 is linked to neoplasm.